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1088-132 Enteral Nutrition Affects Body Composition, Plasma 
Lipids and Cytokines in Cardiac Cachexia: Interim 
Analysis of a Double-Blind, Placebo-Controlled 
Intervention Trial
Rozentryt Piotr, Michalak Alicja, Szewczyk Marta, Chwist-Nowak Aleksandra, Nowak 
Jolanta, Polo_ski Lech, Zembala Marian, Anker D. Stefan, Silesian Center of Heart 
Diseases, Zabrze, Poland, National Heart and Lung Institute, London, United Kingdom
Background. Plasma lipids are suggested as modulators of inflammation. Enteral nutri-
tion (EN) of patients with cardiac cachexia (CC) may change plasma lipids and therefore
alter inflammation.
Methods. We assessed the effects of EN on plasma lipids, body fat content by DEXA,
and cytokines (all in pg/mL). 29 pts with CC (all weight loss>7,5%, 4 female, BM=21,7±2
kg/m2, NYHA 2,7±0,5, LVEF 24±9%) were randomized 3:1 to EN of 600 kcal/day (added
between main meals) (ingredients per 600 kcal: proteins–20g, carbohydrates–72g, fat–
26g) or placebo (clouding agent: 12 kcal/day). 3 pts died: 1–sudden cardiac death, 2- due
to pump failure, 1 was transplanted. Remaining 19 patients (15 M, 4 F, age: 49±15y)
were receiving nutrition, 6 patients placebo. Before nutrition (v1), directly after its with-
drawal, that is 6 weeks after baseline (v2) and 12 weeks thereafter (v3), we performed
DEXA, assessed plasma lipids, cytokines and quality of life by Minnesota score.
Results. Responses noticed in patients receiving EN are shown in the table (paired t-
test, NS=p>0.1).
Conclusions. In patients with CC, EN increased body weight, which was mainly fat
mass. This response was associated with opposite changes of plasma lipids that
increased, and inflammatory cytokines that decreased.
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1089-109 Correlation Between Angiotensin II Receptor Subtype 1 
and Vitronectin Receptor in Cardiac Transplantation
Mohamad H. Yamani, Randall C. Starling, E. Murat Tuzcu, Daniel Cook, Philip Paul, 
Norman B. Ratliff, Yang Yu, Robert Hobbs, Gustavo Rincon, Corinne Bott-Silverman, 
Patrick M. McCarthy, James B. Young, Cleveland Clinic Foundation, Cleveland, OH
Background: Experimental evidence suggests that angiotensin II up-regulates the vit-
ronectin receptor (αVβ3).We have recently shown that recipients of hearts from donors
with spontaneous intracerebral hemorrhage (ICH) are at increased risk of allograft vascu-
lopathy compared to trauma donors. We have also shown that allograft vasculopathy is
associated with up-regulation of αVβ3.
Objectives: This study was undertaken to evaluate the correlation between angiotensin
II receptor subtype 1 (AT1R) and αVβ3 in heart transplant recipients.
Methods: We evaluated mRNA expressions of AT1R and αVβ3 (Real-time PCR, Taq-
Man) in donor spleen lymphocytes (prior to transplantation) and endomyocardial biopsies
(one-week post-transplant) in 20 recipients from ICH donors and 20 recipients from
trauma donors. All patients underwent coronary intravascular ultrasound at baseline and
one-year of transplant to evaluate for transplant vasculopathy.
Results: Baseline characteristics were similar except for increased donor age in the ICH
group. At one week of transplant, heart biopsies from ICH group showed significant
increased expression of αVβ3 (3.8 x fold, P = 0.012) and AT1R (4.7 x fold, P= 0.001)
compared to Trauma group. Further, the ICH group showed significant increased mRNA
expression of αVβ3 (3.5 x fold, P= 0.014) and AT1R (2.6x fold, P=0.004) in the donor
spleen lymphocytes suggesting the presence of systemic activation of both AT1R and
αVβ3 prior to transplantation. At one year, the ICH group showed accelerated progres-
sion of coronary vasculopathy measured as change in coronary intimal thickness (CMIT:
0.69± 0.37 vs 0.39±0.35 mm; P= 0.01), and change in plaque volume (CPV: 6.3± 2.6 vs
4.1±2.5 mm3; P= 0.02) compared to Trauma group. Using multivariate regression analy-
sis both, AT1R and αVβ3 in the donor spleen lymphocytes were independently associ-
ated with coronary vasculopathy. A significant correlation was also noted between AT1R
and αVβ3 (r=0.37, P=0.014) in the donor spleen lymphocytes.
Conclusions: Donor spontaneous intracerebral hemorrhage is associated with systemic
activation of both AT1R and αVβ3. Such an interaction may play a key role in the patho-
genesis of allograft vasculopathy.
1089-110 Mean Annual Change in Duration of QTc Correlates to 
10-Year Survival Following Orthotopic Heart 
Transplantation
Robert E. Eckart, Mark W. Kolasa, Michael D. Kwan, Karl C. Stajduhar, Mark E. Peele, 
Brooke Army Medical Center, Fort Sam Houston, TX
Background: Serial QT interval measurements over time may quantify the degree of
myocardial repolarization heterogeneity. Currently the most routinely used noninvasive
method to assess ventricular recovery time is the QT interval measurement made from
the 12-lead electrocardiogram (ECG). Heterogeneity of recovery time has been sug-
gested to increase the risk of fatal arrhythmias. We sought to examine the correlation
between 10-year survival and ventricular repolarization heterogeneity in the patient with
orthotopic heart transplant (OHT).
Methods: Electrocardiographic records of patients having undergone OHT more than 10
years prior were reviewed. Each patient had their QTc interval charted as a function of
time since undergoing OHT. The slope of each patient’s QTc as a function of time was
then calculated. The slope was then qualified as a change of greater than, or less than
10msec per year.
Results: Thirty-six patients underwent OHT more than 10 years prior. The mean survival
of the cohort was 9.8±5.7 years. The patients had 766 ECGs available for comparison.
When assessing for interventricular conduction delay, there was no clinically significant
difference in mean QRS duration between those surviving beyond 10 years versus those
that died within 10 years (94.0±15.4 vs. 87.6±12.3 msec, p<0.01). The mean QTc change
per year in those surviving versus dying prior to 10 years was 5.5±13.6 vs 20.2±23.8
msec (p=0.024). The survival at 10 years for those with a mean annual QTc change of
less than 10 msec versus greater than 10 msec was 72% versus 14%, respectively
(p=0.008).
Conclusions: Ventricular repolarization heterogeneity, as assessed by serial QTc mea-
surements over time, identifies those patients at increased risk for 10-year mortality fol-
lowing OHT.
1089-111 The Renal Benefit of Calcineurin Inhibitor-Free 
Immunosuppression After Heart Transplantation: Is It 
Safe?
Jon A. Kobashigawa, Jignesh K. Patel, Angela Marquez, Brandy T. Oeser, Jaime D. 
Moriguchi, Hillel Laks, University of California, Los Angeles, CA
Background: The nephrotoxicity of calcineurin inhibitors (CIs) can lead to hemodialysis in
certain patients after heart transplantation. Various strategies have been devised to
reduce the nephrotoxic effects of CIs. Most recently, successful withdrawal of CIs with
immunosuppression consisting of mycophenolate mofetil and sirolimus have been
reported. However, there still remains concern regarding subsequent rejection risk and
the renal benefit of this protocol. Methods: Between 11/02 and 5/03, seven heart trans-
plant patients with serum creatinines > 2.8 mg/dl were entered into our renal sparing pro-
tocol. All patients were on either cyclosporine (6) or tacrolimus (1) along with
mycophenolate + prednisone. For our protocol, sirolimus was added to their regimen at 1
mg/day and titrated to attain a level between 4-8 ng/ml while the current CI dose was
halved. Mycophenolate levels were maintained between 2-5 mcg/ml. When sirolimus lev-
els became therapeutic (usually within 2-4 weeks), the CI was discontinued with endomy-
ocardial biopsy being performed 4 weeks later. Results: 6 of 7 patients had successful
decrease in serum creatinine at two months after discontinuation of CI. One patient (on
cyclosporine) necessitated hemodialysis. The mean serum creatinine of the 6 patients
prior to discontinuation of CI was 3.7 + 0.7 mg/dl (range 2.8 - 4.6 mg/dl) which decreased
to a mean of 2.7 + 0.3 mg/dl (range 2.3 - 3.2 mg/dl), p=0.02. At 4 weeks after discontinu-
ation of CI all echocardiograms were normal and at 6 weeks all endomyocardial biopsies
were negative for rejection (ISHLT grade 0). Conclusion: Renal sparing immunosuppres-
sion with weaning of calcineurin inhibitor and maintenance with mycophenolate and
sirolimus appears safe and effective in heart transplant patients experiencing renal fail-
ure.
1089-112 Acute Rejections During Late Posttransplant Periods in 
Pediatric Heart Transplant Recipients
Michael Dandel, Dagmar Kemper, Lehmkuhl Hans, Martin Bettmann, Rudolf Meyer, 
Onnen Grauhan, Christoph Knosalla, Manfred Hummel, Roland Hetzer, Deutsches 
Herzzentrum Berlin, Berlin, Germany
Previously we showed that acute rejection (AR) surveillance by intramyocardial electro-
gram (IMEG) recordings in children make routine biopsies unncessary and reduce the
mortality linked to ARs. Due to the low incidence of late ARs and their usually harmless
course, IMEG recordings were ended at 2 years after heart transplantation (HTx). How-
ever, the impact of late ARs on the long-term outcome is controversial, especially in chil-
dren. Therefore, we reviewed the late ARs in our patients to evaluate their clinical
relevance.
Methods: All children whith post-HTx time >2 years, who were transplanted between
1986-1999, were reviewed for prevalence and severity of late ARs diagnosed after seces-
sion of IMEG monitoring. Attention was also focused on temporal relationships between
late ARs and the new appearance or aggravation of coronary artery vasculopathy (CAV).
Results: Of the 68 reviewed patients (age 8.3± 5.4 years at HTx), 22 (32.4%) showed 1-
5 clinically relevant late ARs, which occurred for the first time at 5.0± 3.0 years post-HTx.
Of all reviewed patients, 15 (22.1%) died during the study period at 6.7± 3.0 years after
HTx. Of these deaths, 7 (46.7%) occurred during AR, 3 (20 %) were sudden deaths
shortly (2-6 weeks) after AR treatment, 2 (13.3%) were related to severe CAV and 1
Results in nutrition group
Parameter v1 v2 v3. 1vs2 1vs3
Weight [kg] 63.4±10 65.4±10 66.0±11 .00003 .001
Minnesota 47 ± 24 37 ± 24 42 ± 24 .008 .057
Fat–legs [kg] 4.3±1.0 4.8±1.2 5.1±1.1 .005 .004
Fat–trunk [kg] 7.9±2.8 9.0±2.4 9.3±2.4 .01 .01
Fat–total [kg] 15.2±3.4 16.6±3.9 17.2±4.2 .002 .02
TotChol [mmol/L] 5.1±0.9 5.3±1.1 5.7±1.4 NS .03
LDLCH [mmol/L] 3.0±0.9 3.3±1.1 3.6±1.2 NS .01
TNFα [pg/ml] 12.7±17 6.1±9 2.4±3.4 NS .02
TNFα SR I [pg/ml] 2.4±2.7 2.4±1.9 1.1±0.9 NS .063
TNFα SR II [pg/ml] 5.1±3.5 5.0±4.0 3.2±3.7 NS .02
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(6.7% ) to infection. In 2 patients (13.3%) the cause of death was unknown. Of the 10
patients who died in connection with biopsy-proven AR, 6 also had relevant CAV that
developed after the second post-HTx year. In 10 patients with moderate/severe late ARs,
but without CAV during their first episode of late AR diagnosed at 4.6± 3.0 years after
HTx, the angiogram showed relevant CAV lesions 2.4± 1.3 years after the first late AR.
The mean number of late ARs/patient/year was higher in those with angiographic CAV
that developed after the second post-HTx year than in those without CAV after >2 years
since HTx (p<0.01).
Conclusions: Late ARs are the major cause of late allograft dysfunction in children and
may also be involved in the development of CAV. Together with CAV, late ARs are the
dominant cause of death after the second post-HTx year and thus, continuous and close
rejection surveillance late after HTx is justified to improve the long-term outcome.
1089-113 Accuracy of Hemodynamic Measures by Impedance 
Cardiography in Heart Transplant Patients
Amil M. Shah, Susan Wiegers, Susan Brozena, Shashank Desai, Mariell Jessup, Andrew 
Kao, Lee Goldberg, Hospital of the University of Pennsylvania, Philadelphia, PA
Background: The ability to accurately measure cardiac index (CI) non-invasively could
reduce the frequency of surveillance right-heart catheterization (RHC) in post-transplant
patients.Impedance cardiography (IC) has been proposed as an inexpensive, accurate,
and non-invasive method of measuring hemodynamic variables. In this study we evalu-
ated the accuracy of IC in post-heart transplant patients compared to hemodynamic
measurements by Fick method at RHC.
Methods: Post-heart transplant patients undergoing routine RHC for endocardial biopsy
and measurement of hemodynamic variables were enrolled during randomly selected
clinic days. Each patient underwent IC within two hours of RHC. Fick cardiac index (CI)
was calculated using estimated resting VO2. The accuracy of the IC compared to Fick
measurement of CI was evaluated by correlation analysis using the SAS statistical soft-
ware.
Results: 55 patients were enrolled in the study. The average age was 54.6 years old and
the average months post-transplant was 28.4. 78.9% were white, 15.8% African Ameri-
can, 85.7% male. The large majority of patients did not have a significant degree of rejec-
tion on biopsy: 80.4% grade 0 or 1A, 14.3% grade 2, 5.4% grade 3A or 3B. The mean CI
as measured by IC was 2.725 (SD 0.693). The mean CI as measured by Fick method
was 2.885 (SD 0.608). Measurements by the two methods demonstrated a positive cor-
relation with a correlation coefficient(r) of 0.35 and a P value of 0.0087.
Conclusions: Our study population was predominantly white, male, middle aged, and
had a low prevalence of significant rejection. In this population, IC measures of CI do cor-
relate significantly with CI determinations by Fick method in heart transplant patients (p =
0.0087). This suggests that serial measurement of CI by impedance cardiography may
be useful. Relative drops in CI measured by IC may indicate true drops in CI as mea-
sured by Fick method and prompt invasive diagnostic testing. Further studies on the sen-
sitivity of impedance cardiography to help detect cardiac transplant rejection should be
undertaken.
1089-114 C-Reactive Protein but Not Markers of Myocardial 
Necrosis May Preclude Endomyocardial Biopsy for the 
Detection of Cardiac Allograft Rejection
Carlos T. Aguiar, Maria J. Rebocho, Miguel Abecassis, Rafael Hernandez, Nuno Jardim, 
João Figueira, Rosa Gouveia, João Q. Melo, Hospital de Santa Cruz, Carnaxide, 
Portugal
Background: Histological examination of endomyocardial biopsy (EMB) samples remains
the standard for assessing rejection after heart transplantation. However, EMB is expen-
sive, complex, time-consuming, uncomfortable and risky. The purpose of this prospective
study was to evaluate the diagnostic efficacy of C-reactive protein (CRP) and myocardial
necrosis markers (cardiac-specific troponin I: cTnI; creatine-kinase MB mass: CK-MB;
myoglobin: Myo) for the noninvasive detection of cardiac allograft rejection.
Methods: 166 EMB were performed in 41 heart transplant recipients (>10 days postoper-
atively). Blood samples obtained immediately before EMB were assayed for cTnI, CK-
MB, Myo and CRP. Biopsies were graded (0 to 4) according to ISHLT criteria. Biochemi-
cal marker levels were compared to biopsy results. ROC curves were constructed to
determine the CRP level with highest efficiency for the detection of cardiac allograft rejec-
tion grade >= 3 (discriminative value).
Results: Three EMB samples were inappropriate for histological examination. In the
remaining 163 EMB (rejection grade 0 in 110 EMB, 1 in 46, 2 in 1, 3 in 5, and 4 in 1),
there was no significant relation between cardiac allograft rejection grade and cTnI
(p=0.36), CK-MB (p=0.88), and Myo (p=0.42). In contrast, CRP levels increased signifi-
cantly with increasing rejection grade (p=0.02). CRP>=0.4 mg/dl (discriminative value)
demonstrated a 67% sensitivity, 63% specificity, 7% positive predictive value, and 98%
negative PV for the detection of cardiac allograft rejection grade >=3.
Conclusions: In contrast to myonecrosis biomarkers, CRP levels relate to EMB results.
CRP showed a very low positive and a very high negative predictive value for the detec-
tion of moderate to severe rejection. The mode of myocyte injury during rejection may not
represent irreversible cell death.
1089-116 Regional Versus Global Left Ventricular Function in 
Patients After Heart Transplantation: A Doppler 
Myocardial Imaging Study
Margret Kung, Frank Weidemann, Philip Jung, Joerg M. Strotmann, Christiane E. 
Angermann, Medizinische Poliklinik University of Würzburg, Würzburg, Germany
Decreased exercise capacity as well as myocardial structural abnormalities may occur in
patients post heart transplantation (HTx) even in the presence of normal LV systolic func-
tion. This study investigates regional longitudinal motion and deformation properties after
HTx.
Methods: 30 HTx (53,9±9,5 yrs) without evidence of acute rejection or transplant vascu-
lopathy (angiography) and mild to moderate biopsy evidence of interstitial fibrosis were
compared to 20 age-matched controls. Colour Doppler Myocardial Imaging (CDMI) data
were obtained from the mid segment of the interventricular septum and the lateral, infe-
rior and anterior wall. From each segment peak systolic velocity (parameter for motion)
and peak systolic strain rate and systolic strain (parameter for deformation) were
extracted by postprocessing the CDMI data. LV ejection fraction (EF) as a parameter of
global systolic function was assessed by MUGA scans.
Results: LVEF was normal in HTx (57±6%). Also, peak systolic velocities did not differ
(HTx: 3,0±2,9cm/s, controls 2,9±2,8cm/s;NS). However, peak systolic strain rate and
systolic strain were significantly reduced in HTx (figure). No relationship was found
between time post HTx and systolic myocardial function parameters.
Conclusion: This study implies that regional deformation parameters (strain rate and
strain) might be more sensitive for the detection of structural myocardial abnormalities in
HTx than global EF or motion parameters (velocities).
1089-117 Brain Natriuretic Peptide Levels Correspond With 
Diastolic Function Following Orthotopic Heart 
Transplantation
James O. O'Neill, Andrew T. McRae, III, Richard W. Troughton, Kenneth Ng, David O. 
Taylor, Mohammed H. Yamani, James B. Young, Randall C. Starling, Kaufman Center for 
Heart Failure, Cleveland, OH
Background: Orthotopic heart transplantation (OHT) in the early post-operative phase is
associated with restrictive physiology based on hemodynamic and echocardiographic
data. Brain natriuretic peptide (BNP) levels are elevated in patients with non-transplanted
hearts and diastolic impairment. We sought correlation between BNP levels and diastolic
function, as determined by 2 dimensional surface echocardiography, in patients 1 week
after OHT.
Methods: With informed consent, 3 ml of venous blood was drawn and BNP levels were
analyzed using a point of care assay (Biosite Diagnostics ®, San Diego, California) in
patients 1 week following OHT. Two dimensional surface echocardiography was per-
formed within 48 hours of the BNP sampling to assess left ventricular diastolic function.
Peak early (E) and late (A) velocities and early deceleration time (DT) were measured
from pulsed Doppler tracings of transmitral flow.-.
Results: Of 26 OHT patients (25 male, mean age 58 ± 10 years) included in the study,
the mean BNP level was 804 ± 459 pg/mL and the mean left ventricular ejection fraction
was 56 ± 5%. Rejection > grade 2 was present on 18 (69%) of first biopsies. There was
no correlation between E or A wave velocities and BNP levels, but there was a significant
correlation between log-transformed BNP levels and deceleration time and E/A ratio.
Conclusion: Patients have diastolic abnormalities early following OHT and the degree of
abnormality correlates with BNP levels. 
1089-118 Evaluation of the “Normal” Spectrum of Changes in 
Regional Deformation Induced by Heart 
Transplantation: An Ultrasonic Strain and Strain Rate 
Study
Elif Eroglu, Lieven Herbots, Johan Van Cleemput, Walter Droogne, Jan D'hooge, Bart 
Bijnens, Johan Vanhaecke, George R. Sutherland, University Hospital Gasthuisberg, 
Leuven, Belgium
Background: Ultrasonic Strain (S) and Strain rate imaging (SRI) indices are a more sen-
sitive measure of regional myocardial function than standard echo measurements. Thus
they might provide a new tool to define normal graft function in transplant (Tx) pts and to
detect early changes due either to rejection, vasculopathy or drug therapy. Prior to inves-
tigating the role of SRI in detecting such abnormalities, normal Tx S/SR values must be
established as graft regional function could be altered by ischemic time, cardioplegic
arrest or age mismatch.
Methods: 57 pts (age 36±12 y; post Tx 5.5±3 y) were studied. All had normal coronary
angiography, LV ejection fraction, right heart pressure and negative endomyocardial
biopsy. SRI data was acquired from the base, mid and apex of anterior, inferior, septal,
Mean value ± SD Correlation with LnBNP P value
E wave velocity cm/sec 91 ± 22 0.01 NS
A wave velocity cm/sec 43 ± 22 -0.02 NS
E/A ratio 2.2 ± 0.8 0.41 <0.01
Deceleration time ms 167 ± 22 -0.40 <0.05
